Open AccessProinflammatory adipokines and cytokines in abdominal obesity as a factor in the development of atherosclerosis and renal pathology
Author(s) -
E. A. Ryabova,
Yu. I. Ragino
Publication year - 2022
Publication title -
ateroskleroz
Language(s) - English
Resource type - Journals
eISSN - 2949-3633
pISSN - 2078-256X
DOI - 10.52727/2078-256x-2021-17-4-101-110
Subject(s) - adipokine , medicine , adipose tissue , kidney disease , proinflammatory cytokine , context (archaeology) , obesity , abdominal obesity , immunology , bioinformatics , pathology , inflammation , insulin resistance , biology , metabolic syndrome , paleontology
In recent decades, there has been an increase in the prevalence of overweight and obesity. Obesity has become an underestimated pandemic and a public health threat around the world. Adipose tissue is positioned as an endocrine organ that secretes a wide range of pro-inflammatory cytokines and adipokines, inducing a state of chronic subinflammation. The results of epidemiological studies over the past 30 years have also shown that visceral adipose tissue is an independent risk factor for the development of atherosclerosis, cardiometabolic diseases and chronic kidney disease. We performed a systematic review to summarize important aspects of the state of chronic subinflammation in the context of its effect on the decrease in glomerular filtration rate and the development of chronic kidney disease. The review deals with the etiology and pathogenesis of obesity, the hormonal profile of adipose tissue, the molecular mechanisms of the effect of pro-inflammatory cytokines and adipokines on the kidneys, and the pathophysiology of renal diseases. Information on the topic from publications based on the Pubmed database has been used.